NBDC Research ID: hum0191.v1

 

SUMMARY

Aims: To explore prognostic biomarkers using RNAseq data from tumor tissues of resected pancreatic cancer patients

Methods: Analyses of gene expression and lymphocyte enrichment in the tumor tissues by using of RNA-seq data

Participants/Materials: Patients with pancreatic cancer who underwent curative surgery

 

Dataset IDType of DataCriteriaRelease Date
DRA008575 NGS (RNA-seq) Unrestricted-access 2020/06/05

*Release Note

*When the research results including the data which were downloaded from NHA/DRA, are published or presented somewhere, the data user must refer the papers which are related to the data, or include in the acknowledgment. Learn more

 

MOLECULAR DATA

DRA008575
Participants/Materials Pancreatic cancer (ICD10: C25.9): 17 cases
Targets RNA-seq
Target Loci for Capture Methods -
Platform Illumina [HiSeq 1500/4000]
Library Source RNAs extracted from tumor tissues
Cell Lines -
Library Construction (kit name) -
Fragmentation Methods -
Spot Type Single-end / Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 50 bp (SE), 100 bp (PE)
DDBJ Sequence Read Archive ID DRA008575
Total Data Volume 100 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Kazuhiro Kakimi

Affiliation: Department of Immunotherapeutics, The University of Tokyo Hospital

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
KAKENHI Grant-in-Aid for Scientific Research (B) Novel cancer immunotherapy targeting neoantigens in combination with epigenetics and immune modulatio 16H04708
KAKENHI Grant-in-Aid for Scientific Research (C) Development of cancer immunotherapy targeting mutation-derived neoantigens 16K07162

 

PUBLICATIONS

TitleDOIDataset ID
1 NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer doi: 10.1016/j.bbrc.2017.12.083 DRA008575
2